Insider transactions

Jack W Schuler

CIK 1021412 · Chairman · last filed 2026-08-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$142.99M
Companies
20
Total Filings
411
Lifetime Open-Market Net
$217.71M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

AXDX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
PO BOX 531
LAKE BLUFF, IL 60044
Related Filers
MEDTRONIC INC — 47 joint filings, latest 2013-06-27
Jack W. Schuler Living Trust — 17 joint filings, latest 2017-07-13
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BDSX Director 555,810 $10.34 $5.75M $51.95M 47 2026-08-13
Aspira Women's Health Inc. (AWH) Delisted 10%+ Owner 1,918,692 $0.08 $157.3K $8.50M 6 2025-03-10
Accelerate Diagnostics, Inc (AXDX) Delisted Director 25,722 $0.03 $875 $137.68M 186 2024-12-03
YIELD10 BIOSCIENCE, INC. (YTEN) Delisted 10%+ Owner 65,290 $0.35 $22.9K $8.88M 13 2023-12-20
SOLENO THERAPEUTICS INC (SLNO) Delisted 10%+ Owner 46,595 $53.01 $2.47M $13.02M 9 2023-05-15
Aspira Women's Health Inc. (VRML) Delisted 10%+ Owner 29,781,831 — — $11.71M 15 2020-06-11
QDEL Director 6,517,302 $12.09 $78.79M $8.04M 34 2020-05-18
BIOLASE, INC (BIOL) Delisted 10%+ Owner 296 $0.02 $5 $2.22M 8 2020-05-15
SOLENO THERAPEUTICS INC (SLNOW) Delisted 10%+ Owner 4,550,678 — — $4.87M 1 2018-12-26
STERICYCLE INC (SRCLP) Delisted Director 655,482 — — $625.9K 7 2018-05-02
STERICYCLE INC (SRCL) Delisted Director 700,528 $61.98 $43.42M -$71.69M 29 2016-05-27
STERICYCLE INC (SRCL.P) Delisted Director 654,738 — — $0 1 2015-12-23
Neos Therapeutics, Inc. (NEOS) Delisted 10%+ Owner 1,541,149 $1.15 $1.77M $300.0K 1 2015-07-28
YIELD10 BIOSCIENCE, INC. (MBLX) Delisted 10%+ Owner 2,185,652 — — $5.53M 1 2015-06-23
HANSEN MEDICAL INC (HNSN) Delisted Director 1,855,341 — — $0 3 2015-06-15
Oncternal Therapeutics, Inc. (GTXI) Delisted Director 99,155 — — $12.21M 8 2014-03-21
MDT Director 568,617 $102.79 $58.45M $21.27M 31 2013-06-27
Transition Therapeutics Inc. (TTHI) Delisted 10%+ Owner 2,823,010 — — $2.60M 1 2011-11-23
VENTANA MEDICAL SYSTEMS INC (VMSI) Delisted Director 0 — — $0 5 2008-02-20
ICOS CORP (ICOS) Delisted Director 0 — — $0 1 2007-01-30

Recent Filings · Page 8 of 42

411 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-01-20 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +41,912 $165.1K EDGAR
2022-01-18 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +131,219 $524.4K EDGAR
2022-01-12 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +45,226 $196.3K EDGAR
2022-01-06 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +10,000 $49.3K EDGAR
2022-01-04 BDSX Buy (P) +2,298,850 $10.00M EDGAR
2022-01-04 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +997 $4.9K EDGAR
2021-12-30 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +57,062 $276.8K EDGAR
2021-12-22 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +54,541 $258.0K EDGAR
2021-12-21 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +74,127 $369.2K EDGAR
2021-12-20 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +20,000 $92.0K EDGAR
Showing 71–80 of 411
Page 8 of 42
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.